top of page
COVID-19 & Sports
COVID-19 & Sports
COVID-19 & Sports
Career
Contact Us
Vancouver Infectious Diseases Centre
About Us
About Dr. Conway
About Dr. Truong
Services
Clinical Services
HCV / HIV Patient Care
Research Involvement
Community Outreach
VUHC
Published Work
Press
Radio
Webinars
Hantavirus
HCV & HIV Care
COVID & Sports
COVID-19: 2022 - Present
COVID-19
DONATE
More
Use tab to navigate through the menu items.
Published Work
From observational studies to clinical trials, the VIDC research team shares our findings with the medical community at international conferences.
Visit us at an upcoming conference >
All Posts
Conference Poster
Research Paper
Blog
Search
Glecaprevir/pibrentasvir for the treatment of hepatitis C virus infection among active drug users
Glecaprevir/pibrentasvir for the treatment of hepatitis C virus infection among active drug users: the GRAND PLAN study Presented at the...
Feb 28, 2020
Sofosbuvir/velpatasvir (S/V) for the treatment of chronic HCV in active drug users: the CHIME study
Presented at the Canadian Liver Meeting. February 28- March 1, Montreal, Canada, 2020.
Feb 28, 2020
Overdose events among active drug users successfully treated for HCV: the impact of homelessness.
Presented at the Canadian Liver Meeting. February 28- March 1, Montreal, Canada, 2020.
Feb 28, 2020
Efficacité du sofosbuvir/velpatasvir et de l'elbasvir/grazoprevir pour le traitement du VHC de génot
Efficacité du sofosbuvir/velpatasvir et de l'elbasvir/grazoprévir pour le traitement de l'infection par le VHC de génotype 1 dans une...
Nov 8, 2019
Suivi à long terme des personnes qui consomment des drogues (PWUD) suite à un traitement VHC réussi
Suivi à long terme des personnes qui consomment des drogues (PWUD) suite à un traitement réussi contre le VHC : habitudes de consommation...
Nov 8, 2019
bottom of page
